Essential Tips for Safeguarding Your Medicines in Hot Weather

Urgent Call for Flu Vaccination in the UK

The UK Health Security Agency (UKHSA) is calling on all individuals eligible for a complimentary flu vaccination to schedule their appointments at the earliest opportunity, as cases of influenza continue to escalate throughout England. Recent data indicates that this year’s flu season has commenced earlier than anticipated, with a significant rise in infections particularly noted among children, alongside indications of broader community transmission.

Statistics reveal a striking increase in flu-related prescriptions, which more than doubled compared to the previous year, soaring from approximately 283,000 to 659,000. This article details the implications of these figures, the reasons behind the rise in prescriptions, and what this signifies for patients, healthcare professionals, and the NHS.

Understanding Medical Cannabis Prescribing Patterns

In the UK, medical cannabis is classified as a controlled substance produced to meet stringent pharmaceutical standards. It is subject to rigorous monitoring and regulatory oversight, distinguishing it from illicit or recreational cannabis. Understanding the distinction between prescription figures and the actual number of patients receiving treatment is crucial in discussions surrounding medical cannabis data.

Medical cannabis is often prescribed as a long-term treatment, leading to multiple prescriptions for individual patients throughout the year. Consequently, the data reflects prescription counts rather than the unique patients receiving treatment. Only doctors listed on the GMC Specialist Register are authorised to initiate prescriptions for unlicensed cannabis-based medicines, a process that necessitates thorough evaluation, careful dosage, and ongoing patient monitoring.

Research indicates that the economic advantages of medical cannabis could be substantial. A recent health economics study projected that prescribing medical cannabis for chronic pain could yield savings of approximately £729 million annually for the NHS. Moreover, an analysis by the Centre for Economics and Business Research estimated that broader NHS access to medical cannabis could contribute up to £13.3 billion to the UK economy over the next decade, primarily through enhanced health outcomes and increased workforce participation.

Common Conditions Treated with Medical Cannabis

Data from UK sources such as Project Twenty21 and the UK Medical Cannabis Registry demonstrates that medical cannabis is most frequently prescribed for chronic pain conditions, including arthritis, neurological disorders like epilepsy and Parkinson’s disease, mental health issues such as PTSD and generalised anxiety disorder, gastrointestinal disorders including Crohn’s disease, and cancer-related symptoms, as well as for palliative care. The Medical Cannabis Clinicians Society advocates for a cautious, evidence-based prescribing approach, offering continuing professional development (CPD) accredited education, prescribing guidance, peer support, and ongoing training for medical professionals.

Since its legalisation for prescription in November 2018, the uptake of medical cannabis in the UK has been relatively slow. The recent uptick in prescriptions is a reflection of gradual changes within the healthcare system rather than an abrupt expansion.

Protecting Medicines from Heat Damage

As temperatures soar, it is essential to consider the storage of medications. Heat can compromise the efficacy of medicines, rendering them less effective or even unsafe. With the frequency of heatwaves increasing in the UK, understanding how to store medications safely is becoming increasingly vital.

Medicines are often more sensitive to temperature than the public may realise. Many are intended to be stored below 25°C, ideally between 15°C and 25°C, while specific medications may require refrigeration at temperatures between 2°C and 8°C. When the temperature exceeds 25°C, the chemical composition of certain medications can begin to deteriorate, affecting their effectiveness.

Moreover, excessive heat can lead to the separation of creams, evaporation of liquids, or melting of capsules. The Medicines and Healthcare products Regulatory Agency (MHRA) cautions that heat can adversely affect tablets, inhalers, insulin, and other common treatments.

Understanding the Risks of Heat Exposure

As proteins change shape when exposed to excessive heat, medications may not function effectively. For instance, insulin’s potency can diminish with rising temperatures, which is why manufacturers recommend keeping unopened insulin vials in the fridge and using opened pens or vials at room temperature for limited periods. Similarly, GLP-1 medications, often used for type 2 diabetes and weight management, are protein-based and should also be stored in cool conditions to maintain efficacy.

Research has shown that salbutamol inhalers can deliver reduced dosages when subjected to high summer temperatures, while glucose meters can yield falsely elevated readings if exposed to heat and humidity. Everyday environments, such as parked cars or sunny windowsills, can subject medications to extreme temperatures, with parked vehicles sometimes exceeding 40°C on warm days.

Best Practices for Medicine Storage During Heatwaves

With approximately half of UK homes experiencing overheating during heatwaves, particularly older properties that retain warmth, it is crucial to be vigilant about medication storage. Bathrooms pose additional risks due to fluctuating humidity and temperature, with many individuals storing medications in kitchens and bathrooms where conditions can vary significantly.

While brief exposure to warmth may not significantly compromise medicines, prolonged periods of high temperatures can lead to chemical breakdown and reduced potency. Keeping a room thermometer in the coolest area of the home, away from sunlight, can help monitor conditions. However, in homes that overheat, it may be prudent to consider investing in air conditioning, even portable units for specific rooms, as only around 19% of households in Great Britain currently have air conditioning.

When travelling, extra precautions should be taken as medications can heat up in bags or pockets. It is advisable to carry them in insulated pouches or cool bags, avoiding direct contact with ice packs, as freezing can also be detrimental. Leaving medications in a parked car should always be avoided.

Recognising Signs of Heat-Damaged Medicines

It is important to be aware of the indicators of heat-damaged medications. Tablets may appear soft, crumble, or change colour, while liquids may become cloudy or form crystals. Inhalers might feel warm or deliver weaker doses. Any noticeable changes in appearance or performance should be discussed with a pharmacist. For users of insulin and GLP-1 medications, unexplained high blood sugar readings could signal potential damage to the medicine.

While heatwaves may offer a welcome respite from the typical British weather, they present hidden risks for medicinal products. As temperatures rise, ensuring the proper storage of medicines is as crucial as protecting one’s skin. Keeping medications cool, checking for any alterations, and avoiding direct sunlight can help guarantee their effectiveness.